Regeneron Has Strong Showing, But No REGEN-COV Sales Expected In First Half

Analysts Highlight Potential Growth Opportunities

4th quarter computer key on key board
Regeneron reported its fourth quarter and full year 2021 sales on 4 February • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business